Magnetic Resonance Imaging + Antiandrogen Therapy + Biospecimen Collection + Positron Emission Tomography + Stereotactic Body Radiation Therapy + Survey Administration for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Jan 2024: Trial registered, NCT06205316
  2. 4 Apr 2024: Trial started, NCT06205316

The trials

NCT06205316: SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

State
Under way
Phase
Phase 3
People
118 taking part
Started
4 Apr 2024
Primary completion
25 Sep 2028
Arms
Group I (SBRT)
Results
None posted
  1. 16 Jan 2024: Trial registered
  2. 4 Apr 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.